April 2021 – Page 2 – Policy & Medicine

DOJ FY 2020 Year in Review and Looking Forward to FY 2021

MedPAC Advocates for Continued Telemedicine Flexibilities

California Puts Forth Draft Standards Regarding CME Activities, Implicit Bias

Should CMS Reduce its Portfolio of APMs?

New House Bill Aims to Expand Access to Genetic Counseling, Drive Down Healthcare Costs

Smartphone App to Support COVID-19 Long Haulers (Long COVID)

Federal Appeals Court Rules in Favor of Regeneron and Sanofi in Patent Litigation

FDA Unveils Data Modernization Plan

FDA to Focus on Patients with Rare Diseases

Telemedicine Fraud Catches the Eye of HHS OIG